Literature DB >> 9454627

Neurotrophins prevent death and differentially affect tyrosine hydroxylase of adult rat nigrostriatal neurons in vivo.

T Hagg1.   

Abstract

Brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and neurotrophin-4 (NT-4) promote survival of mesencephalic dopaminergic neurons in vitro and affect normal and damaged ones in vivo. Here, these neurotrophins had markedly different potencies to prevent the death of axotomized nigrostriatal dopaminergic neurons when infused close to the rostral end of the nigral nucleus of adult rats (NT-4 > BDNF > NT-3; nerve growth factor or NGF without effect). With a high dose of BDNF (30 micrograms/day) complete protection was achieved in the rostral but not caudal nigral regions, consistent with its poor diffusion characteristics in brain tissue. Measurements of tyrosine hydroxylase immunoreactivity suggest that BDNF and NT-4 (presumably through their TrkB receptor) reduce the synthesis of this rate-limiting enzyme for dopamine synthesis in rescued as well as in normal neurons. In sharp contrast, survival-promoting doses of NT-3 (presumably through its TrkC receptor) maintained normal levels of tyrosine hydroxylase immunoreactivity in the rescued nigrostriatal neurons. These results suggest that for these adult central nervous system neurons, some neurotrophic factors are predominantly involved in facilitating cell survival, whereas others are more involved in regulating neurotransmitter function.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9454627     DOI: 10.1006/exnr.1997.6684

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  19 in total

1.  Functional regeneration in a rat Parkinson's model after intrastriatal grafts of glial cell line-derived neurotrophic factor and transforming growth factor beta1-expressing extra-adrenal chromaffin cells of the Zuckerkandl's organ.

Authors:  E F Espejo; M C Gonzalez-Albo; J P Moraes; F El Banoua; J A Flores; I Caraballo
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

2.  Activation of signaling pathways following localized delivery of systemically administered neurotrophic factors across the blood-brain barrier using focused ultrasound and microbubbles.

Authors:  Babak Baseri; James J Choi; Thomas Deffieux; Gesthimani Samiotaki; Yao-Sheng Tung; Oluyemi Olumolade; Scott A Small; Barclay Morrison; Elisa E Konofagou
Journal:  Phys Med Biol       Date:  2012-03-09       Impact factor: 3.609

3.  Neurotrophic factors in neurodegenerative disorders: model of Parkinson's disease.

Authors:  J Garcia de Yebenes; J Yebenes; M A Mena
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

4.  Neurotrophin receptor heterozygosity causes deficits in catecholaminergic innervation of amygdala and hippocampus in aged mice.

Authors:  O von Bohlen Und Halbach; L Minichiello
Journal:  J Neural Transm (Vienna)       Date:  2006-06-01       Impact factor: 3.575

5.  M-tropic HIV envelope protein gp120 exhibits a different neuropathological profile than T-tropic gp120 in rat striatum.

Authors:  Alessia Bachis; Maria I Cruz; Italo Mocchetti
Journal:  Eur J Neurosci       Date:  2010-07-28       Impact factor: 3.386

6.  The TrkB-positive dopaminergic neurons are less sensitive to MPTP insult in the substantia nigra of adult C57/BL mice.

Authors:  Yin-Xiu Ding; Yi Xia; Xi-Ying Jiao; Li Duan; Jun Yu; Xi Wang; Liang-Wei Chen
Journal:  Neurochem Res       Date:  2011-05-12       Impact factor: 3.996

7.  Positive modulation of AMPA receptors increases neurotrophin expression by hippocampal and cortical neurons.

Authors:  J C Lauterborn; G Lynch; P Vanderklish; A Arai; C M Gall
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

8.  Developmental expression of neurotrophins and their receptors in postnatal rat ventral midbrain.

Authors:  Suzanne Numan; Christine M Gall; Kim B Seroogy
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

9.  TrkB neurotrophic activities are blocked by α-synuclein, triggering dopaminergic cell death in Parkinson's disease.

Authors:  Seong Su Kang; Zhentao Zhang; Xia Liu; Fredric P Manfredsson; Matthew J Benskey; Xuebing Cao; Jun Xu; Yi E Sun; Keqiang Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-18       Impact factor: 11.205

10.  Involvement of BDNF in age-dependent alterations in the hippocampus.

Authors:  Oliver von Bohlen und Halbach
Journal:  Front Aging Neurosci       Date:  2010-08-13       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.